Shortened Activated Partial Thromboplastin Time Is Associated With Acute Ischemic Stroke, Stroke Severity, and Neurological Worsening

The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischem...

Full description

Saved in:
Bibliographic Details
Published inJournal of stroke and cerebrovascular diseases Vol. 24; no. 10; pp. 2270 - 2276
Main Authors Lin, Chun-Hsien, Kuo, Ya-Wen, Kuo, Chih-Yu, Huang, Yen-Chu, Hsu, Chia-Yu, Hsu, Huan-Lin, Lin, Ya-Hui, Wu, Chih-Ying, Huang, Ying-Chih, Lee, Meng, Yang, Hsin-Ta, Pan, Yi-Ting, Lee, Jiann-Der
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.10.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischemic strokes with the shortened APTT. The study population consisted of 154 patients with acute ischemic strokes who had been admitted from December 2013 to December 2014 to the Department of Neurology, Chiayi Chang Gung Memorial Hospital, and 71 control subjects with no history of stroke. In a univariate risk analysis, shortened APTT was associated with an odds ratio (OR) for acute ischemic strokes of up to 1.86 (95% confidence interval [CI], 1.06-3.29, P = .031). In a multivariate analysis using a logistic regression model including age, sex, hypertension, diabetes mellitus, and shortened APTT, shortened APTT was still found to significantly add to the risk of ischemic stroke (OR = 2.12 with 95% CI, 1.13-3.98, P = .020). Shortened APTT was also associated significantly with neurological worsening (OR = 3.72 with 95% CI 1.03-13.5, P = .046). As for stroke severity, shortened APTT was associated with an OR for moderate/severe stroke of up to 3.42 (95% CI, 1.53-7.61, P = .003). Shortened APTT is a prevalent and independent risk factor for ischemic stroke, stroke severity, and neurological worsening after acute stroke.
AbstractList The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischemic strokes with the shortened APTT. The study population consisted of 154 patients with acute ischemic strokes who had been admitted from December 2013 to December 2014 to the Department of Neurology, Chiayi Chang Gung Memorial Hospital, and 71 control subjects with no history of stroke. In a univariate risk analysis, shortened APTT was associated with an odds ratio (OR) for acute ischemic strokes of up to 1.86 (95% confidence interval [CI], 1.06-3.29, P = .031). In a multivariate analysis using a logistic regression model including age, sex, hypertension, diabetes mellitus, and shortened APTT, shortened APTT was still found to significantly add to the risk of ischemic stroke (OR = 2.12 with 95% CI, 1.13-3.98, P = .020). Shortened APTT was also associated significantly with neurological worsening (OR = 3.72 with 95% CI 1.03-13.5, P = .046). As for stroke severity, shortened APTT was associated with an OR for moderate/severe stroke of up to 3.42 (95% CI, 1.53-7.61, P = .003). Shortened APTT is a prevalent and independent risk factor for ischemic stroke, stroke severity, and neurological worsening after acute stroke.
The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischemic strokes with the shortened APTT. The study population consisted of 154 patients with acute ischemic strokes who had been admitted from December 2013 to December 2014 to the Department of Neurology, Chiayi Chang Gung Memorial Hospital, and 71 control subjects with no history of stroke. In a univariate risk analysis, shortened APTT was associated with an odds ratio (OR) for acute ischemic strokes of up to 1.86 (95% confidence interval [CI], 1.06-3.29, P = .031). In a multivariate analysis using a logistic regression model including age, sex, hypertension, diabetes mellitus, and shortened APTT, shortened APTT was still found to significantly add to the risk of ischemic stroke (OR = 2.12 with 95% CI, 1.13-3.98, P = .020). Shortened APTT was also associated significantly with neurological worsening (OR = 3.72 with 95% CI 1.03-13.5, P = .046). As for stroke severity, shortened APTT was associated with an OR for moderate/severe stroke of up to 3.42 (95% CI, 1.53-7.61, P = .003). Shortened APTT is a prevalent and independent risk factor for ischemic stroke, stroke severity, and neurological worsening after acute stroke.
The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischemic strokes with the shortened APTT.BACKGROUNDThe role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischemic strokes with the shortened APTT.The study population consisted of 154 patients with acute ischemic strokes who had been admitted from December 2013 to December 2014 to the Department of Neurology, Chiayi Chang Gung Memorial Hospital, and 71 control subjects with no history of stroke.METHODSThe study population consisted of 154 patients with acute ischemic strokes who had been admitted from December 2013 to December 2014 to the Department of Neurology, Chiayi Chang Gung Memorial Hospital, and 71 control subjects with no history of stroke.In a univariate risk analysis, shortened APTT was associated with an odds ratio (OR) for acute ischemic strokes of up to 1.86 (95% confidence interval [CI], 1.06-3.29, P = .031). In a multivariate analysis using a logistic regression model including age, sex, hypertension, diabetes mellitus, and shortened APTT, shortened APTT was still found to significantly add to the risk of ischemic stroke (OR = 2.12 with 95% CI, 1.13-3.98, P = .020). Shortened APTT was also associated significantly with neurological worsening (OR = 3.72 with 95% CI 1.03-13.5, P = .046). As for stroke severity, shortened APTT was associated with an OR for moderate/severe stroke of up to 3.42 (95% CI, 1.53-7.61, P = .003).RESULTSIn a univariate risk analysis, shortened APTT was associated with an odds ratio (OR) for acute ischemic strokes of up to 1.86 (95% confidence interval [CI], 1.06-3.29, P = .031). In a multivariate analysis using a logistic regression model including age, sex, hypertension, diabetes mellitus, and shortened APTT, shortened APTT was still found to significantly add to the risk of ischemic stroke (OR = 2.12 with 95% CI, 1.13-3.98, P = .020). Shortened APTT was also associated significantly with neurological worsening (OR = 3.72 with 95% CI 1.03-13.5, P = .046). As for stroke severity, shortened APTT was associated with an OR for moderate/severe stroke of up to 3.42 (95% CI, 1.53-7.61, P = .003).Shortened APTT is a prevalent and independent risk factor for ischemic stroke, stroke severity, and neurological worsening after acute stroke.CONCLUSIONShortened APTT is a prevalent and independent risk factor for ischemic stroke, stroke severity, and neurological worsening after acute stroke.
Background The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischemic strokes with the shortened APTT. Methods The study population consisted of 154 patients with acute ischemic strokes who had been admitted from December 2013 to December 2014 to the Department of Neurology, Chiayi Chang Gung Memorial Hospital, and 71 control subjects with no history of stroke. Results In a univariate risk analysis, shortened APTT was associated with an odds ratio (OR) for acute ischemic strokes of up to 1.86 (95% confidence interval [CI], 1.06-3.29, P  = .031). In a multivariate analysis using a logistic regression model including age, sex, hypertension, diabetes mellitus, and shortened APTT, shortened APTT was still found to significantly add to the risk of ischemic stroke (OR = 2.12 with 95% CI, 1.13-3.98, P  = .020). Shortened APTT was also associated significantly with neurological worsening (OR = 3.72 with 95% CI 1.03-13.5, P  = .046). As for stroke severity, shortened APTT was associated with an OR for moderate/severe stroke of up to 3.42 (95% CI, 1.53-7.61, P  = .003). Conclusion Shortened APTT is a prevalent and independent risk factor for ischemic stroke, stroke severity, and neurological worsening after acute stroke.
Author Wu, Chih-Ying
Pan, Yi-Ting
Lin, Chun-Hsien
Lee, Meng
Huang, Ying-Chih
Hsu, Huan-Lin
Kuo, Chih-Yu
Lin, Ya-Hui
Kuo, Ya-Wen
Huang, Yen-Chu
Lee, Jiann-Der
Hsu, Chia-Yu
Yang, Hsin-Ta
Author_xml – sequence: 1
  givenname: Chun-Hsien
  orcidid: 0000-0003-0942-7492
  surname: Lin
  fullname: Lin, Chun-Hsien
  organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan
– sequence: 2
  givenname: Ya-Wen
  surname: Kuo
  fullname: Kuo, Ya-Wen
  organization: Department of Nursing, Asia University, Taichung, Taiwan
– sequence: 3
  givenname: Chih-Yu
  surname: Kuo
  fullname: Kuo, Chih-Yu
  organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan
– sequence: 4
  givenname: Yen-Chu
  surname: Huang
  fullname: Huang, Yen-Chu
  organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan
– sequence: 5
  givenname: Chia-Yu
  surname: Hsu
  fullname: Hsu, Chia-Yu
  organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan
– sequence: 6
  givenname: Huan-Lin
  surname: Hsu
  fullname: Hsu, Huan-Lin
  organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan
– sequence: 7
  givenname: Ya-Hui
  surname: Lin
  fullname: Lin, Ya-Hui
  organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan
– sequence: 8
  givenname: Chih-Ying
  surname: Wu
  fullname: Wu, Chih-Ying
  organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan
– sequence: 9
  givenname: Ying-Chih
  surname: Huang
  fullname: Huang, Ying-Chih
  organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan
– sequence: 10
  givenname: Meng
  surname: Lee
  fullname: Lee, Meng
  organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan
– sequence: 11
  givenname: Hsin-Ta
  surname: Yang
  fullname: Yang, Hsin-Ta
  organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan
– sequence: 12
  givenname: Yi-Ting
  surname: Pan
  fullname: Pan, Yi-Ting
  organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan
– sequence: 13
  givenname: Jiann-Der
  surname: Lee
  fullname: Lee, Jiann-Der
  email: jdlee540908@gmail.com
  organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26169548$$D View this record in MEDLINE/PubMed
BookMark eNqVks-O0zAQhyO0iP0Dr4ByRGgb7Lh2kgtSdwXsogqQWrTcLMeZbKeb2MV2KvUBeG-cbeGwgkNPM5I_fxrNb86TE2MNJMlbSjJKqHi3ztY-OPsAGhzUzm6Vb9BnOaE8IyIjpHyWnFHO8knJKT2JPeH5hBFenCbn3q8JoZSX_EVymgsqKj4tz5Jfi5V1AQw06UwH3KoQu2_KBVRdulw529d20ykf0KRL7CG99enMe6vxkbzDsIofhzA-6BX0qNPF44yXh5ouYAsOw-4yVaZJv8DgbGfvUUf_nXUeDJr7l8nzVnUeXh3qRfL944fl9c1k_vXT7fVsPtG8EmGSl03LNBNTVpMaBBe0KiqmmypnnDUlq9uWKNVOC0abQpQaWF60RcUpY1PeCsIukjd778bZnwP4IHv0GrpOGbCDl7SgZRVpLiL6-oAOdQ-N3DjsldvJP6uLwNUe0M5676D9i1Aix7zkWv4rLznmJYmQMa8ouXki0RhUQGuCU9gdp5rvVRAXuEVw0msEo6FBBzrIxuJxuvdPdLpDM8b2ADvwazs4E6OSVPpcErkYb208NcoJYYz9iILP_xccO81vELz2mg
CitedBy_id crossref_primary_10_1371_journal_pone_0240483
crossref_primary_10_1002_epi4_12249
crossref_primary_10_1007_s00415_017_8696_4
crossref_primary_10_1177_1076029616631424
crossref_primary_10_1080_09637486_2016_1268101
crossref_primary_10_2147_CIA_S357639
crossref_primary_10_1111_ijlh_12897
crossref_primary_10_2174_1567202620666221027093103
crossref_primary_10_29121_ijrsm_v7_i11_2020_2
crossref_primary_10_1038_s41598_021_83157_5
crossref_primary_10_1155_2022_1901256
crossref_primary_10_3389_fcvm_2021_769857
crossref_primary_10_1016_j_jstrokecerebrovasdis_2015_10_021
crossref_primary_10_1097_MBC_0000000000000947
crossref_primary_10_3390_life14091158
crossref_primary_10_4081_vl_2024_12592
crossref_primary_10_1007_s00484_020_01868_2
crossref_primary_10_1002_acn3_733
crossref_primary_10_1016_j_bbadis_2017_04_015
crossref_primary_10_2174_0118744400298093240520070257
Cites_doi 10.1161/01.STR.25.11.2220
10.1159/000355685
10.1161/01.CIR.99.14.1780
10.1161/01.CIR.95.3.594
10.1182/blood-2010-03-277079
10.1182/blood.V88.10.3698.bloodjournal88103698
10.1001/jama.1980.03300480018016
10.1055/s-0038-1642511
10.1161/01.CIR.100.7.736
10.1161/01.ATV.17.11.3321
10.1212/WNL.0b013e3182918d38
10.2174/1567202612666150102153447
10.1182/blood-2001-11-0140
10.1111/j.1538-7836.2007.02467.x
10.1016/S0140-6736(95)90166-3
10.1182/blood-2004-03-1042
10.1161/ATVBAHA.107.155952
10.1182/blood.V95.12.3678
10.1160/TH06-12-0719
10.1056/NEJM200003093421004
10.1182/blood-2005-12-023697
10.1161/01.STR.0000126890.63512.41
10.1055/s-0032-1301415
10.1309/G98J-ANA9-RMNC-XLYU
10.1016/S0049-3848(00)00380-7
10.1016/j.jstrokecerebrovasdis.2006.11.002
10.1161/01.STR.27.8.1296
10.2174/1567202610666131202115038
10.1097/00001721-200109000-00011
10.1055/s-0037-1613369
10.1046/j.1538-7836.2003.00459.x
10.1016/j.amjmed.2007.10.025
10.1160/TH11-11-0804
10.1073/pnas.0932632100
ContentType Journal Article
Copyright 2015 National Stroke Association
National Stroke Association
Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2015 National Stroke Association
– notice: National Stroke Association
– notice: Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jstrokecerebrovasdis.2015.06.008
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-8511
EndPage 2276
ExternalDocumentID 26169548
10_1016_j_jstrokecerebrovasdis_2015_06_008
S105230571500333X
1_s2_0_S105230571500333X
Genre Journal Article
GrantInformation_xml – fundername: Chang Gung Memorial Hospital
  grantid: CMRPG6C0632
GroupedDBID ---
--K
--M
.1-
.55
.FO
.~1
0R~
1B1
1P~
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABMAC
ABMZM
ABTEW
ABWVN
ABXDB
ACDAQ
ACIEU
ACJTP
ACRLP
ACRPL
ADBBV
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AEVXI
AFJKZ
AFRHN
AFTJW
AFXBA
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
GROUPED_DOAJ
HVGLF
HZ~
IHE
J1W
KOM
L7B
M2W
M41
MO0
N9A
O-L
O9-
OAUVE
OP~
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SDF
SDG
SEL
SES
SEW
SNG
SNH
SPCBC
SSH
SSZ
T5K
X7M
Z5R
~G-
AACTN
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AISVY
AJBFU
EFLBG
LCYCR
NAHTW
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c596t-28df3c3643b0be65619793cd92353d83bff0aaf4731d768ce327f79513345f603
IEDL.DBID .~1
ISSN 1052-3057
1532-8511
IngestDate Thu Jul 10 22:58:47 EDT 2025
Wed Feb 19 01:58:41 EST 2025
Thu Apr 24 22:55:22 EDT 2025
Tue Jul 01 00:46:23 EDT 2025
Fri Feb 16 04:41:21 EST 2024
Sun Feb 23 10:19:24 EST 2025
Tue Aug 26 16:55:49 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords ischemic
association
Stroke
risk
activated partial thromboplastin time
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c596t-28df3c3643b0be65619793cd92353d83bff0aaf4731d768ce327f79513345f603
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-0942-7492
PMID 26169548
PQID 1718913356
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1718913356
pubmed_primary_26169548
crossref_primary_10_1016_j_jstrokecerebrovasdis_2015_06_008
crossref_citationtrail_10_1016_j_jstrokecerebrovasdis_2015_06_008
elsevier_sciencedirect_doi_10_1016_j_jstrokecerebrovasdis_2015_06_008
elsevier_clinicalkeyesjournals_1_s2_0_S105230571500333X
elsevier_clinicalkey_doi_10_1016_j_jstrokecerebrovasdis_2015_06_008
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-10-01
PublicationDateYYYYMMDD 2015-10-01
PublicationDate_xml – month: 10
  year: 2015
  text: 2015-10-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of stroke and cerebrovascular diseases
PublicationTitleAlternate J Stroke Cerebrovasc Dis
PublicationYear 2015
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Ananyeva, Kouiavskaia, Shima (bib1) 2002; 99
Torshin (bib15) 2007
Berge, Friis, Sandset (bib34) 2001; 101
Zakai, Ohira, White (bib35) 2008; 121
Folsom, Rosamond, Shahar (bib20) 1999; 100
Kuo, Lin, Kuo (bib21) 2015; 12
Koster, Blann, Briet (bib5) 1995; 345
White (bib16) 2003; 1
Koster, Rosendaal, Reitsma (bib19) 1994; 71
Toschi, Gallo, Lettino (bib12) 1997; 95
Kvistad, Logallo, Oygarden (bib32) 2013; 36
Doggen, Rosendaal, Meijers (bib8) 2006; 108
Prandoni (bib17) 2007; 5
Madi, Greci, Nawaz (bib25) 2001; 12
Lyden, Brott, Tilley (bib10) 1994; 25
Pinelli, Trivulzio, Rossoni (bib26) 2014; 28
Sandercock, Counsell, Kamal (bib38) 2008
(bib11) 1980; 243
Lee, Hsiao, Lee (bib22) 2012; 11
van Hylckama Vlieg, van der Linden, Bertina (bib6) 2000; 95
Gentile, Vaidyula, Kanamalla (bib31) 2007; 98
Martinez-Sanchez, Fuentes, Martinez-Martinez (bib29) 2013; 80
Hjalmarsson, Manhem, Bokemark (bib30) 2014; 2014
Douxfils, Mullier, Robert (bib37) 2012; 107
Feinberg, Erickson, Bruck (bib33) 1996; 27
Barber, Langhorne, Rumley (bib27) 2004; 35
Gailani, Renne (bib2) 2007; 27
Jiang, Doolittle (bib3) 2003; 100
Smith, Lee, Fowkes (bib14) 1997; 17
Tripodi, Chantarangkul, Martinelli (bib24) 2004; 104
Poort, Rosendaal, Reitsma (bib18) 1996; 88
Korte, Clarke, Lefkowitz (bib9) 2000; 113
Martinelli, Girelli, Lunghi (bib23) 2010; 116
Davidson, Hirt, Lal (bib4) 2003; 89
Harenberg, Erdle, Marx (bib36) 2012; 38
Meijers, Tekelenburg, Bouma (bib7) 2000; 342
Badimon, Lettino, Toschi (bib13) 1999; 99
Barrett, Brott, Brown (bib28) 2007; 16
Smith (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib14) 1997; 17
Poort (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib18) 1996; 88
Hjalmarsson (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib30) 2014; 2014
Koster (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib5) 1995; 345
Douxfils (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib37) 2012; 107
Folsom (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib20) 1999; 100
van Hylckama Vlieg (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib6) 2000; 95
Prandoni (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib17) 2007; 5
Martinelli (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib23) 2010; 116
Barrett (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib28) 2007; 16
Barber (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib27) 2004; 35
Berge (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib34) 2001; 101
Kvistad (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib32) 2013; 36
Torshin (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib15) 2007
Jiang (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib3) 2003; 100
Kuo (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib21) 2015; 12
Sandercock (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib38) 2008
Meijers (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib7) 2000; 342
Madi (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib25) 2001; 12
Gentile (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib31) 2007; 98
(10.1016/j.jstrokecerebrovasdis.2015.06.008_bib11) 1980; 243
Lee (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib22) 2012; 11
White (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib16) 2003; 1
Lyden (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib10) 1994; 25
Koster (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib19) 1994; 71
Badimon (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib13) 1999; 99
Zakai (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib35) 2008; 121
Gailani (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib2) 2007; 27
Pinelli (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib26) 2014; 28
Harenberg (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib36) 2012; 38
Davidson (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib4) 2003; 89
Toschi (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib12) 1997; 95
Korte (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib9) 2000; 113
Feinberg (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib33) 1996; 27
Martinez-Sanchez (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib29) 2013; 80
Doggen (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib8) 2006; 108
Ananyeva (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib1) 2002; 99
Tripodi (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib24) 2004; 104
References_xml – volume: 71
  start-page: 719
  year: 1994
  end-page: 722
  ident: bib19
  article-title: Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms—the Leiden Thrombophilia Study (LETS)
  publication-title: Thromb Haemost
– volume: 5
  start-page: 270
  year: 2007
  end-page: 275
  ident: bib17
  article-title: Venous thromboembolism and atherosclerosis: is there a link?
  publication-title: J Thromb Haemost
– volume: 243
  start-page: 2296
  year: 1980
  end-page: 2297
  ident: bib11
  article-title: From the NIH: New standards for classification and diagnosis of diabetes
  publication-title: JAMA
– volume: 345
  start-page: 152
  year: 1995
  end-page: 155
  ident: bib5
  article-title: Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
  publication-title: Lancet
– volume: 100
  start-page: 7527
  year: 2003
  end-page: 7532
  ident: bib3
  article-title: The evolution of vertebrate blood coagulation as viewed from a comparison of puffer fish and sea squirt genomes
  publication-title: Proc Natl Acad Sci U S A
– year: 2007
  ident: bib15
  article-title: Physiology and medicine
– volume: 11
  start-page: 10
  year: 2012
  end-page: 15
  ident: bib22
  article-title: Genetic polymorphism of LDLR (rs688) is associated with primary intracerebral hemorrhage
  publication-title: Curr Neurovasc Res
– start-page: CD000024
  year: 2008
  ident: bib38
  article-title: Anticoagulants for acute ischaemic stroke
  publication-title: Cochrane Database Syst Rev
– volume: 27
  start-page: 1296
  year: 1996
  end-page: 1300
  ident: bib33
  article-title: Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome
  publication-title: Stroke
– volume: 95
  start-page: 3678
  year: 2000
  end-page: 3682
  ident: bib6
  article-title: High levels of factor IX increase the risk of venous thrombosis
  publication-title: Blood
– volume: 89
  start-page: 420
  year: 2003
  end-page: 428
  ident: bib4
  article-title: Molecular evolution of the vertebrate blood coagulation network
  publication-title: Thromb Haemost
– volume: 121
  start-page: 231
  year: 2008
  end-page: 238
  ident: bib35
  article-title: Activated partial thromboplastin time and risk of future venous thromboembolism
  publication-title: Am J Med
– volume: 12
  start-page: 85
  year: 2015
  end-page: 90
  ident: bib21
  article-title: Factor VIII levels are associated with ischemic stroke, stroke subtypes and neurological worsening
  publication-title: Curr Neurovasc Res
– volume: 100
  start-page: 736
  year: 1999
  end-page: 742
  ident: bib20
  article-title: Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study investigators
  publication-title: Circulation
– volume: 101
  start-page: 13
  year: 2001
  end-page: 21
  ident: bib34
  article-title: Hemostatic activation in acute ischemic stroke
  publication-title: Thromb Res
– volume: 2014
  start-page: 694569
  year: 2014
  ident: bib30
  article-title: The role of prestroke glycemic control on severity and outcome of acute ischemic stroke
  publication-title: Stroke Res Treat
– volume: 108
  start-page: 4045
  year: 2006
  end-page: 4051
  ident: bib8
  article-title: Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII
  publication-title: Blood
– volume: 35
  start-page: 1421
  year: 2004
  end-page: 1425
  ident: bib27
  article-title: Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression
  publication-title: Stroke
– volume: 17
  start-page: 3321
  year: 1997
  end-page: 3325
  ident: bib14
  article-title: Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh artery study
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 16
  start-page: 34
  year: 2007
  end-page: 39
  ident: bib28
  article-title: Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke
  publication-title: J Stroke Cerebrovasc Dis
– volume: 88
  start-page: 3698
  year: 1996
  end-page: 3703
  ident: bib18
  article-title: A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
  publication-title: Blood
– volume: 104
  start-page: 3631
  year: 2004
  end-page: 3634
  ident: bib24
  article-title: A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism
  publication-title: Blood
– volume: 1
  start-page: 2267
  year: 2003
  end-page: 2270
  ident: bib16
  article-title: The partial thromboplastin time: defining an era in coagulation
  publication-title: J Thromb Haemost
– volume: 116
  start-page: 5688
  year: 2010
  end-page: 5697
  ident: bib23
  article-title: Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile
  publication-title: Blood
– volume: 25
  start-page: 2220
  year: 1994
  end-page: 2226
  ident: bib10
  article-title: Improved reliability of the NIH stroke scale using video training. NINDS TPA stroke study group
  publication-title: Stroke
– volume: 342
  start-page: 696
  year: 2000
  end-page: 701
  ident: bib7
  article-title: High levels of coagulation factor XI as a risk factor for venous thrombosis
  publication-title: N Engl J Med
– volume: 80
  start-page: 1800
  year: 2013
  end-page: 1805
  ident: bib29
  article-title: Treatment with statins and ischemic stroke severity: does the dose matter?
  publication-title: Neurology
– volume: 98
  start-page: 1007
  year: 2007
  end-page: 1013
  ident: bib31
  article-title: Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia
  publication-title: Thromb Haemost
– volume: 95
  start-page: 594
  year: 1997
  end-page: 599
  ident: bib12
  article-title: Tissue factor modulates the thrombogenicity of human atherosclerotic plaques
  publication-title: Circulation
– volume: 28
  start-page: 99
  year: 2014
  end-page: 104
  ident: bib26
  article-title: Activated partial thromboplastin time correlates with methoxyhydroxyphenylglycol in acute myocardial infarction patients: therapeutic implications for patients at cardiovascular risk
  publication-title: In Vivo
– volume: 27
  start-page: 2507
  year: 2007
  end-page: 2513
  ident: bib2
  article-title: Intrinsic pathway of coagulation and arterial thrombosis
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 107
  start-page: 985
  year: 2012
  end-page: 997
  ident: bib37
  article-title: Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate
  publication-title: Thromb Haemost
– volume: 113
  start-page: 123
  year: 2000
  end-page: 127
  ident: bib9
  article-title: Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism
  publication-title: Am J Clin Pathol
– volume: 38
  start-page: 178
  year: 2012
  end-page: 184
  ident: bib36
  article-title: Determination of rivaroxaban in human plasma samples
  publication-title: Semin Thromb Hemost
– volume: 99
  start-page: 1780
  year: 1999
  end-page: 1787
  ident: bib13
  article-title: Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions
  publication-title: Circulation
– volume: 12
  start-page: 495
  year: 2001
  end-page: 499
  ident: bib25
  article-title: The activated partial thromboplastin time in early diagnosis of myocardial infarction
  publication-title: Blood Coagul Fibrinolysis
– volume: 36
  start-page: 351
  year: 2013
  end-page: 354
  ident: bib32
  article-title: Elevated admission blood pressure and stroke severity in acute ischemic stroke: the Bergen NORSTROKE study
  publication-title: Cerebrovasc Dis
– volume: 99
  start-page: 4475
  year: 2002
  end-page: 4485
  ident: bib1
  article-title: Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque
  publication-title: Blood
– volume: 25
  start-page: 2220
  year: 1994
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib10
  article-title: Improved reliability of the NIH stroke scale using video training. NINDS TPA stroke study group
  publication-title: Stroke
  doi: 10.1161/01.STR.25.11.2220
– volume: 36
  start-page: 351
  year: 2013
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib32
  article-title: Elevated admission blood pressure and stroke severity in acute ischemic stroke: the Bergen NORSTROKE study
  publication-title: Cerebrovasc Dis
  doi: 10.1159/000355685
– volume: 99
  start-page: 1780
  year: 1999
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib13
  article-title: Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions
  publication-title: Circulation
  doi: 10.1161/01.CIR.99.14.1780
– volume: 95
  start-page: 594
  year: 1997
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib12
  article-title: Tissue factor modulates the thrombogenicity of human atherosclerotic plaques
  publication-title: Circulation
  doi: 10.1161/01.CIR.95.3.594
– volume: 2014
  start-page: 694569
  year: 2014
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib30
  article-title: The role of prestroke glycemic control on severity and outcome of acute ischemic stroke
  publication-title: Stroke Res Treat
– volume: 116
  start-page: 5688
  year: 2010
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib23
  article-title: Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile
  publication-title: Blood
  doi: 10.1182/blood-2010-03-277079
– volume: 88
  start-page: 3698
  year: 1996
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib18
  article-title: A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
  publication-title: Blood
  doi: 10.1182/blood.V88.10.3698.bloodjournal88103698
– volume: 243
  start-page: 2296
  year: 1980
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib11
  article-title: From the NIH: New standards for classification and diagnosis of diabetes
  publication-title: JAMA
  doi: 10.1001/jama.1980.03300480018016
– volume: 71
  start-page: 719
  year: 1994
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib19
  article-title: Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms—the Leiden Thrombophilia Study (LETS)
  publication-title: Thromb Haemost
  doi: 10.1055/s-0038-1642511
– volume: 100
  start-page: 736
  year: 1999
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib20
  article-title: Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study investigators
  publication-title: Circulation
  doi: 10.1161/01.CIR.100.7.736
– volume: 17
  start-page: 3321
  year: 1997
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib14
  article-title: Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh artery study
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.17.11.3321
– volume: 80
  start-page: 1800
  year: 2013
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib29
  article-title: Treatment with statins and ischemic stroke severity: does the dose matter?
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3182918d38
– volume: 12
  start-page: 85
  year: 2015
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib21
  article-title: Factor VIII levels are associated with ischemic stroke, stroke subtypes and neurological worsening
  publication-title: Curr Neurovasc Res
  doi: 10.2174/1567202612666150102153447
– volume: 99
  start-page: 4475
  year: 2002
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib1
  article-title: Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque
  publication-title: Blood
  doi: 10.1182/blood-2001-11-0140
– year: 2007
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib15
– volume: 5
  start-page: 270
  issue: suppl 1
  year: 2007
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib17
  article-title: Venous thromboembolism and atherosclerosis: is there a link?
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2007.02467.x
– volume: 345
  start-page: 152
  year: 1995
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib5
  article-title: Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(95)90166-3
– volume: 104
  start-page: 3631
  year: 2004
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib24
  article-title: A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism
  publication-title: Blood
  doi: 10.1182/blood-2004-03-1042
– volume: 27
  start-page: 2507
  year: 2007
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib2
  article-title: Intrinsic pathway of coagulation and arterial thrombosis
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.107.155952
– volume: 95
  start-page: 3678
  year: 2000
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib6
  article-title: High levels of factor IX increase the risk of venous thrombosis
  publication-title: Blood
  doi: 10.1182/blood.V95.12.3678
– volume: 98
  start-page: 1007
  year: 2007
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib31
  article-title: Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia
  publication-title: Thromb Haemost
  doi: 10.1160/TH06-12-0719
– start-page: CD000024
  issue: 8
  year: 2008
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib38
  article-title: Anticoagulants for acute ischaemic stroke
  publication-title: Cochrane Database Syst Rev
– volume: 342
  start-page: 696
  year: 2000
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib7
  article-title: High levels of coagulation factor XI as a risk factor for venous thrombosis
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200003093421004
– volume: 108
  start-page: 4045
  year: 2006
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib8
  article-title: Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII
  publication-title: Blood
  doi: 10.1182/blood-2005-12-023697
– volume: 35
  start-page: 1421
  year: 2004
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib27
  article-title: Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression
  publication-title: Stroke
  doi: 10.1161/01.STR.0000126890.63512.41
– volume: 38
  start-page: 178
  year: 2012
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib36
  article-title: Determination of rivaroxaban in human plasma samples
  publication-title: Semin Thromb Hemost
  doi: 10.1055/s-0032-1301415
– volume: 113
  start-page: 123
  year: 2000
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib9
  article-title: Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism
  publication-title: Am J Clin Pathol
  doi: 10.1309/G98J-ANA9-RMNC-XLYU
– volume: 101
  start-page: 13
  year: 2001
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib34
  article-title: Hemostatic activation in acute ischemic stroke
  publication-title: Thromb Res
  doi: 10.1016/S0049-3848(00)00380-7
– volume: 28
  start-page: 99
  year: 2014
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib26
  article-title: Activated partial thromboplastin time correlates with methoxyhydroxyphenylglycol in acute myocardial infarction patients: therapeutic implications for patients at cardiovascular risk
  publication-title: In Vivo
– volume: 16
  start-page: 34
  year: 2007
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib28
  article-title: Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke
  publication-title: J Stroke Cerebrovasc Dis
  doi: 10.1016/j.jstrokecerebrovasdis.2006.11.002
– volume: 27
  start-page: 1296
  year: 1996
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib33
  article-title: Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome
  publication-title: Stroke
  doi: 10.1161/01.STR.27.8.1296
– volume: 11
  start-page: 10
  year: 2012
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib22
  article-title: Genetic polymorphism of LDLR (rs688) is associated with primary intracerebral hemorrhage
  publication-title: Curr Neurovasc Res
  doi: 10.2174/1567202610666131202115038
– volume: 12
  start-page: 495
  year: 2001
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib25
  article-title: The activated partial thromboplastin time in early diagnosis of myocardial infarction
  publication-title: Blood Coagul Fibrinolysis
  doi: 10.1097/00001721-200109000-00011
– volume: 89
  start-page: 420
  year: 2003
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib4
  article-title: Molecular evolution of the vertebrate blood coagulation network
  publication-title: Thromb Haemost
  doi: 10.1055/s-0037-1613369
– volume: 1
  start-page: 2267
  year: 2003
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib16
  article-title: The partial thromboplastin time: defining an era in coagulation
  publication-title: J Thromb Haemost
  doi: 10.1046/j.1538-7836.2003.00459.x
– volume: 121
  start-page: 231
  year: 2008
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib35
  article-title: Activated partial thromboplastin time and risk of future venous thromboembolism
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2007.10.025
– volume: 107
  start-page: 985
  year: 2012
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib37
  article-title: Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate
  publication-title: Thromb Haemost
  doi: 10.1160/TH11-11-0804
– volume: 100
  start-page: 7527
  year: 2003
  ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib3
  article-title: The evolution of vertebrate blood coagulation as viewed from a comparison of puffer fish and sea squirt genomes
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0932632100
SSID ssj0011585
Score 2.1697154
Snippet The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the...
Background The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT)...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2270
SubjectTerms activated partial thromboplastin time
Adult
Aged
Aged, 80 and over
association
Brain Ischemia - complications
Cardiovascular
Female
Humans
ischemic
Lipoproteins - metabolism
Male
Middle Aged
Nervous System Diseases - etiology
Neurology
Partial Thromboplastin Time
Retrospective Studies
risk
Stroke
Stroke - complications
Stroke - etiology
Thromboplastin - metabolism
Time Factors
Title Shortened Activated Partial Thromboplastin Time Is Associated With Acute Ischemic Stroke, Stroke Severity, and Neurological Worsening
URI https://www.clinicalkey.com/#!/content/1-s2.0-S105230571500333X
https://www.clinicalkey.es/playcontent/1-s2.0-S105230571500333X
https://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.06.008
https://www.ncbi.nlm.nih.gov/pubmed/26169548
https://www.proquest.com/docview/1718913356
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBelg7KX0X1n3YoGexr1YluWHbOnEFrSjZZBWpo3IckScbfZwXZe97b_e3eynDGWPQT25C9JlnSn0--k0x0h75JCSq6UAua1oKBY0FnzQoVBpLMiDlWsuMQF_avrdH6bfFry5QGZDWdh0KzSy_5epjtp7d-MfW-O12U5XkRuRZNnAGlCxtgST7AnGXL5hx9bMw8APC4sJyYOMPURef_bxuu-7Zr6q9GmAQUUbT-LEl14R9z59MSQk7snq3-BUTcpXRyTRx5N0mlf4cfkwFRPyNGV3y9_Sn4uVmhMC6KUTrULZAZ3X7B9kOtm1dTfVb0G_NyVFcXDIPSypQPBIOVd2a0g46bDD9q5FqAL15Yzf6ULA2MBkPwZlVVBnasPL03pXd20BpddnpHbi_Ob2TzwgRcCzfO0C-JJYZlmAFZUqAwgviiHYawLAIOcFROmrA2ltEnGogLUFW1YnNksx1AxCbdpyJ6Tw6quzEtCbQpFhFobBbjF8lQVuUYXhFIaySKbjch06GGhvVdyDI7xTQzmZ_diF5UEUkk4m7zJiHzclrHufXTslXs2EFYMp1FBfgqYUvYqJdtVimm9SGhFJNpYhOIvth2R823OPzh_7xq8HbhSgIjAfR9ZmXoDfwb8kQNteDoiL3p23fYTKNAp-vx79Z9qcUIe4lNv7viaHHbNxrwB2NapUzcuT8mD6eXn-fUvTpVLDg
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9swEBbbLGx7KX03farQU1kT24rsmJ5C2CXpbkIhWTY3oSfxtrWD7fyE_u-OZDmlND0EerKxPLKsGY2-kUYzCH0cKs6pEAKE14CBYsBmzZQIg0imKg5FLCi3C_rzRTK9GX5Z0_UJmnRnYaxbpdf9rU532to_GfjeHGzzfLCM3IomTQHShISQ9T10aqNT0R46Hc-upov9ZkJEXWZO-35gCc7Qp99uXnd1U5XftNQV2KDW_VPlNop3RF1YT5t18vB89S886ualy0fooQeUeNy2-TE60cUTdDb3W-ZP0c_lxvrTgjbFY-lymcHdV_uLQLXaVOUPUW4BQjd5ge15EDyrccczePM2bzZAuGtsgXTRBfDS_cu5v-KlhuEAYP4c80JhF-3DK1R8W1a1tisvz9DN5cVqMg187oVA0ixpgnikDJEE8IoIhQbQF2UwkqUCPEiJGhFhTMi5GaYkUmCxSE3i1KSZzRYzpCYJyXPUK8pCv0TYJFBFKKUWAF0MTYTKpI1CyLnmJDJpH427HmbSBya3-TG-s84D7Y4d4hKzXGLOLW_UR5_3dWzbMB1HUU86xrLuQCqoUAazylG1pIdq0bXXCjWLWB2zkP0luX10saf8Q_iPbsGHTioZaAm79cMLXe7gywBBMuANTfroRSuu-34CGzqxYf9e_adWvEf3p6v5NbueLa5eowe2pPV-fIN6TbXTbwHFNeKdH6W_AGsNTb8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Shortened+Activated+Partial+Thromboplastin+Time+Is+Associated+With+Acute+Ischemic+Stroke%2C+Stroke+Severity%2C+and+Neurological+Worsening&rft.jtitle=Journal+of+stroke+and+cerebrovascular+diseases&rft.au=Lin%2C+Chun-Hsien%2C+MD&rft.au=Kuo%2C+Ya-Wen%2C+PhD&rft.au=Kuo%2C+Chih-Yu%2C+MD&rft.au=Huang%2C+Yen-Chu%2C+MD&rft.date=2015-10-01&rft.issn=1052-3057&rft.volume=24&rft.issue=10&rft.spage=2270&rft.epage=2276&rft_id=info:doi/10.1016%2Fj.jstrokecerebrovasdis.2015.06.008&rft.externalDBID=ECK1-s2.0-S105230571500333X&rft.externalDocID=1_s2_0_S105230571500333X
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10523057%2FS1052305714X0011X%2Fcov150h.gif